Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$24.98
-1.85%today
MKT CAP
$876M
-4.5% · 1Y
Earnings History
+9.9%
-8.6%
+18.8%
+11.8%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$24.98
Low
$21.00
Analyst Mean
$35.24
High
$50.00
10 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-9.2x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership6.3%
Institutional Ownership76.3%
Short % of Float7.48%
Days to Cover5.7d
1 Week+5.4%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| SAVITZ ADAM | Officer | Buy | 15,000 | $12.53 | $0.19M | 2024-07-10 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Alpha Wave Global, LP | institution | 11.61% | $0.09B | +0.00% | 2025-12-31 |
| Vestal Point Capital, LP | institution | 7.78% | $0.06B | +161.58% | 2025-12-31 |
| Commodore Capital Lp | institution | 5.71% | $0.05B | +100.00% | 2025-12-31 |
| Perceptive Advisors Llc | institution | 5.59% | $0.04B | +1048.51% | 2025-12-31 |
| Point72 Asset Management, L.P. | institution | 5.03% | $0.04B | +20.60% | 2025-12-31 |
| Armistice Capital, LLC | institution | 4.81% | $0.04B | -6.11% | 2025-12-31 |
| Vanguard Group Inc | institution | 4.28% | $0.03B | +23.56% | 2025-12-31 |
| Franklin Resources, Inc. | institution | 3.50% | $0.03B | -3.70% | 2025-12-31 |
| Vivo Capital, LLC | institution | 3.24% | $0.03B | +100.00% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.74% | $0.02B | +24.08% | 2025-12-31 |
| 72 Investment Holdings, LLC | institution | 2.09% | $0.02B | +0.00% | 2025-12-31 |
| Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND | fund | 1.27% | $0.01B | +0.00% | 2026-01-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.91% | $0.01B | +28.59% | 2025-12-31 |
| iShares Trust-iShares Biotechnology ETF | fund | 0.67% | $0.01B | +3.58% | 2026-03-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | fund | 0.44% | $0.00B | -0.36% | 2026-02-28 |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | fund | 0.23% | $0.00B | +100.00% | 2026-03-31 |
| AdvisorShares Trust-AdvisorShares Psychedelics ETF | fund | 0.18% | $0.00B | +0.00% | 2026-02-28 |
| iShares Trust-iShares Micro-Cap ETF | fund | 0.18% | $0.00B | +0.47% | 2026-03-31 |
| Bridgeway Funds, Inc.-Ultra-Small Company Market Fund | fund | 0.16% | $0.00B | +0.00% | 2025-12-31 |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | fund | 0.15% | $0.00B | +0.00% | 2026-02-28 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for ANRO.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.